See All Companies

TR50 Company Profile

Organovo

Why: Its three-dimensional artificial tissue structures can be used for drug testing and are likely to find therapeutic applications.

Key innovation: A printing process methodically deposits layers of cells and gel material to build up new tissues.

Public Company: Organovo

Headquarters: San Diego
Founded: 2007
Market Capitalization: $120 million

Advertisement
Advertisement